Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HAVCR2 | Q8TDQ0 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28227844 | 0.84 | CYP1A2 (0.38) | CYP1A2CYP2C19TDP1L3MBTL1LMNA | |
| SCHEMBL27591807 | 0.82 | LMNA (0.36) | CYP1A2CYP2C19TDP1L3MBTL1LMNA | |
| SCHEMBL19914848 | 0.80 | CYP1A2 (0.42) | CYP1A2CYP2C19TDP1L3MBTL1LMNA | |
| SCHEMBL23846799 | 0.78 | L3MBTL1 (0.50) | CYP1A2CYP2C19TDP1L3MBTL1LMNA | |
| SCHEMBL21284909 | 0.78 | CYP1A2 (0.35) | CYP1A2CYP2C19TDP1L3MBTL1LMNA | |
| SCHEMBL286417 | 0.78 | TRPV4 (0.34) | TDP1L3MBTL1LMNAALDH1A1HPGD | |
| SCHEMBL30294701 | 0.78 | TRPV4 (0.34) | TDP1L3MBTL1LMNAALDH1A1HPGD | |
| SCHEMBL6379593 | 0.78 | GRM6 (0.36) | TDP1L3MBTL1LMNAALDH1A1HPGD | |
| SCHEMBL7975208 | 0.77 | CYP1A2 (0.46) | CYP1A2CYP2C19TDP1L3MBTL1LMNA | |
| SCHEMBL31050110 | 0.77 | CYP1A2 (0.46) | CYP1A2CYP2C19TDP1L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270244-A1 | ORGANOMETALLIC COMPLEX, LIGHT-EMITTING MATERIAL FOR TOP EMISSION, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| US-12325716-B2 | Organometallic complex, light-emitting material for top emission, light-emitting device, light-emitting apparatus, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-06-10 | — | — | US | disclosed |
| US-20210214381-A1 | ORGANOMETALLIC COMPLEX, LIGHT-EMITTING MATERIAL FOR TOP EMISSION, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-07-15 | — | — | US | disclosed |
| CN-113105508-A | Organometallic complex, top-emission light-emitting material, light-emitting device, light-emitting apparatus, electronic device, and lighting apparatus | 株式会社半导体能源研究所 | 2021-07-13 | — | — | CN | disclosed |
| CN-102134214-B | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators | ASTRAZENECA AB | 2013-05-22 | — | — | CN | disclosed |
| EP-0899255-B1 | Fungicidal 2,6,6'-trimethylbenzophenones | BASF AG (DE) | 2003-04-02 | — | — | EP | disclosed |
| US-6242498-B1 | NONPHYTOTOXIC | BASF AKTIENGESELLSCHAFT | 2001-06-05 | — | — | US | disclosed |
| EP-0899255-A2 | Fungicidal 2,6,6'-trimethylbenzophenones | American Cyanamid Company (US) | 1999-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12325716-B2 | Organometallic complex, light-emitting material for top emission, light-emitting device, light-emitting apparatus, electronic device, and lighting device | CRY1, LIG4, LIG1 | CYP1A2 733/4885CYP2C19 696/4885TDP1 2716/4885 |
| US-20210214381-A1 | ORGANOMETALLIC COMPLEX, LIGHT-EMITTING MATERIAL FOR TOP EMISSION, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE | CRY1, LIG4, LIG1 | CYP1A2 733/4885CYP2C19 696/4885TDP1 2716/4885 |
| US-20250270244-A1 | ORGANOMETALLIC COMPLEX, LIGHT-EMITTING MATERIAL FOR TOP EMISSION, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE | CRY1, LIG4, LIG1 | CYP1A2 733/4885CYP2C19 696/4885TDP1 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.